ChemicalBook >> CAS DataBase List >>KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO

KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO

CAS No.
6740-88-1
Chemical Name:
KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO
Synonyms
2-(2-chlorophenyl)-2-methylamino-cyclohexan-1-one;Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (±)- (8CI);C07525;Ketoject;NSC 70151;dl-Ketamine;Fluorexetamine;(+-)-cyclohexanon;Esketamine impurity D CRS;Esketamine Hydrochloride EP Impurity D
CBNumber:
CB3503704
Molecular Formula:
C13H16ClNO
Molecular Weight:
237.73
MDL Number:
MOL File:
6740-88-1.mol
Last updated:2024-12-18 14:08:52

KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO Properties

Melting point 92-93°
Boiling point 363.8±42.0 °C(Predicted)
Density 1.0982 (rough estimate)
refractive index 1.6330 (estimate)
pka 7.5(at 25℃)
FDA UNII 690G0D6V8H
EPA Substance Registry System Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (6740-88-1)

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302+H332
RIDADR  3249
HazardClass  6.1(b)
PackingGroup  III
Hazardous Substances Data 6740-88-1(Hazardous Substances Data)

KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO Chemical Properties,Uses,Production

Originator

Ketanest,Parke Davis,W. Germany,1969

Uses

Anesthetic.

Definition

ChEBI: Ketamine is a member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group. It has a role as an intravenous anaesthetic, a NMDA receptor antagonist, an analgesic, a neurotoxin, an environmental contaminant and a xenobiotic. It is a member of cyclohexanones, a secondary amino compound and a member of monochlorobenzenes.

Manufacturing Process

The 1-hydroxycyclopentyl-(o-chlorophenyl)-ketone N-methylimine used as an intermediate is prepared as follows. To the Grignard reagent prepared from 119.0 g of cyclopentyl bromide and 19.4 g of magnesium is added 55.2 g of o-chlorobenzonitrile. The reaction mixture is stirred for 3 days and thereafter hydrolyzed in the usual manner. From the hydrolysis there is obtained ochlorophenylcyclopentylketone, BP 96° to 97°C (0.3 mm), nD251.5452. To 21.0 g of the ketone is added 10.0 g of bromine in 80 ml of carbon tetrachloride.
1-Bromocyclopentyl-(o-chlorophenyl)-ketone, BP 111° to 114°C (0.1 mm) is isolated in the usual manner. Since it is unstable, it must be used immediately. The bromoketone (29.0 g) is dissolved in 50 ml of liquid methylamine. After one hour, the excess liquid methylamine is allowed to evaporate. The organic residue is dissolved in pentane, and upon evaporation of the solvent, 1-hydroxycyclopentyl-(o-chlorophenyl)-ketone N-methylimine, MP 62°C, is isolated.
1-Hydroxycyclopentyl-(o-chlorophenyl)-ketone N-methylimine (2.0 g) is dissolved in 15 ml of Decalin and refluxed for 2,5 hours. After evaporation of the Decalin under reduced pressure, the residue is extracted with dilute hydrochloric acid, the solution treated with decolorizing charcoal, and the resulting acidic solution is made basic. The liberated product, 2-methylamino- 2-(o-chlorophenyl)-cyclohexanone, after crystallization from pentane-ether, has MP 92° to 93°C. The hydrochloride of this compound has MP 262° to 263°C.

brand name

Ketalar (Parkdale).

Therapeutic Function

Anesthetic

Mechanism of action

The mode of action of ketamine differs from that of the barbiturates. It suppresses the activities of the cerebral cortex (consciousness) and the thalamic pain pathways (analgesia). Parts of the upper brainstem and the limbic system are not affected (so-called dissociative analgesia). The patient exhibits a characteristic superficial sleep with complete elimination of pain. Because of the psychomotor side effects, combination with neuroleptics and tranquilizers is necessary. Ketamine is used especially in pediatrics. The usual preparations are 0.1 % and 0.5 % solutions.

Clinical Use

Ketamine is a short-acting anesthetic effective for 5 – 30 min, depending on the amount injected. It is suitable for diagnostic purposes and for surgical procedures that do not require muscle relaxation. The occasional hallucinations that occur during anesthesia suggest a chemical relationship to phencyclidine, which was used as a short-acting anesthetic until identified as a dangerous drug of abuse.

Synthesis

It is prepared by bromination of o-chlorophenyl cyclopentyl ketone, which is then reacted with methylamine to give the methylimino alcohol. Thermolysis of the imino hydrochloride yields ketamine by ring expansion :
Synthesis_6740-88-1

1867-66-9
6740-88-1
Synthesis of KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO from Ketamine hydrochloride

KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO Preparation Products And Raw materials

6740-88-1(KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO)Related Search:

2-(2-chlorophenyl)-2-methylaminocyclohexanone Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (±)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI) dl-Ketamine Ketoject NSC 70151 C07525 (+-)-cyclohexanon 2-(methylamino)-2-(2-chlorophenyl)cyclohexanone KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO KETAMINE HYDROCHLORIDE SELECTIVE NMDA AN TAGO USP/EP/BP 2-(2-chlorophenyl)-2-methylamino-cyclohexan-1-one Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (±)- (8CI) Esketamine Hydrochloride EP Impurity D Esketamine impurity D CRS Fluorexetamine 6740-88-1